Earth Science Tech, Inc. (ETST) Reports Third Fiscal Quarter 2026 Results
17-Feb-2026 08:30:03 EST
Earth Science Tech, Inc. (ETST) Reports Third Fiscal Quarter 2026 Results
GlobeNewswire February 17, 2026
Revenue of $8.4 million, up 14.1% year-over-year
Gross profit margin of 76.3%, up 71 bps year-over-year
Net income of $910,000, up 341% year-over-year
Generated positive cash from operations of $1.2 million fiscal year-to-date
Peaks, the company's telemedicine platform, surpasses $2.0 million in revenue in less than a year, scaling from $248,000 into a highâ€'margin growth platform
Reduced outstanding shares of common stock by 3.6% year over year through share repurchases
Geographic expansion underway with up to 10 additional state licenses pending
Strong calendar 2026 performance signals positive trajectory for fiscal Q4
MIAMI, Feb. 17, 2026 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today announced its financial and operational results for the third fiscal quarter ended December 31, 2025.
“We exited the third fiscal quarter with strong strategic momentum and continued progress across our diversified platform,” said Giorgio R. Saumat, CEO and Chairman of the Board of Earth Science Tech, Inc. “Results were largely consistent with the prior quarter and reflected typical seasonality, including holiday timing and temporary macro and supply-related headwinds. Importantly, multiple operating units are now generating positive cash flow, underscoring the strength and resilience of our portfolio approach.”
Mr. Saumat continued, “While our reported results reflect the current stage of our growth and investment cycle, they do not yet fully capture the operating leverage inherent in the model. Moving ahead, we see a clear and verifiable path to a materially higher earnings baseline through expense rationalization and scale, a view reinforced by our ongoing share repurchases and my longâ€'term ownership position acquired entirely with cash. With calendar 2026 off to a strong start and several geographic and product expansion initiatives underway, we believe the Company is well positioned for accelerating growth in the periods ahead.”
Fiscal Q3 2026 Key Financial Highlights
Revenue of $8.4 million, up 14.1% compared to $7.4 million for the three months ended December 31, 2024
Gross profit of $6.4 million, or a gross margin of 76.3%, as compared to $5.1 million or a gross margin of 69.2%, for the three months ended December 31, 2024, an increase of $1.3 million, or 25.8% on a dollar basis
Net Income of $910,000, up 341.0% compared to $206,000 for the three months ended December 31, 2024
Total Assets of $8.1 million, up 14.5% compared to $7.1 million at March 31, 2025
Repurchased and retired 3,703,296 shares of common stock for the nine months ended December 31, 2025
Third Fiscal Quarter 2026 Financial Results
Revenue
Revenue for the three months ended December 31, 2025, was $8.4 million, an increase of 14%, as compared to $7.4 million during the third quarter of last year primarily due to an increase in product sales.
Gross Profit/Margin
Gross profit for the third quarter of fiscal 2026 was $6.4 million, or a 76.3% gross margin, compared to gross profit of $5.1 million, or a 69.2% gross margin, for the same period in 2024. The increase in gross profit was primarily attributable to higher product sales, with incremental volume contributing to improved operating leverage and margin expansion.
Operating Expenses
For the three months ended December 31, 2025, operating expenses were $5.1 million as compared to $4.9 million for the same period in 2024. The increase in operating expenses was primarily the result of an increase in advertising and marketing and office/selling, general and administrative expenses, which were partially offset by a decrease in salaries expense.
Net Income
Net income was $910,000, or $0.003 per diluted share, for the three months ended December 31, 2025, as compared to $206,000, or $0.001 for the same period in 2024.
Adjusted EBITDA
Adjusted EBITDA was $1.2 million for the three months ended December 31, 2025, as compared to $0.3 million for the same period in 2024.
Balance Sheet
As of December 31, 2025, the Company had $416,000 of cash on hand and working capital of $773,000, compared to $1.5 million of cash on hand and working capital of ($36,000) as of March 31, 2025. The decrease in cash on hand is primarily due to investments in inventory to support higher sales volumes and improve product availability, as well as increased operating activity during the period. The Company had no bank debt as of December 31, 2025.
The Company repurchased and retired 1,143,000 and 3,703,296 shares of its common stock for the three and nine months ended December 31, 2025, respectively.
Conference Call and Webcast:
The Company will host a conference call and webcast to discuss its second fiscal quarter results, highlights, and outlook at 5:00 Eastern Time. To participate in the telephone conference call please dial in at least 15 minutes prior to start time.
In addition to disclosing financial results in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), this document references certain non-GAAP financial measures. The Company defines Adjusted EBITDA as earnings excluding interest, tax, depreciation and amortization. We believe these non-GAAP financial measures provide investors with useful supplemental information about our operating performance and enable comparison of financial trends and results between periods where certain items may vary, independent of business performance.
Please refer to “Reconciliation of Non-GAAP Measures” in this document for a detailed explanation of the adjustments made to the comparable U.S. GAAP measures.
About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. is a diversified holding company focused on the health and wellness sector. Through its wholly-owned subsidiaries, ETST operates a vertically integrated portfolio that includes high-quality compounding pharmacies, telemedicine platforms, and targeted healthcare facilities. The Company currently owns RxCompoundStore.com and Mister Meds, two licensed compounding pharmacies providing sterile and non-sterile medications across a growing network of U.S. states. These operations are supported by Peaks Curative, DOConsultation.com, and Las Villas Health Care, providing patients with personalized care, telemedicine connectivity, and clinical support.
Beyond healthcare, ETST manages Avenvi, its real estate and asset management arm, and 80% of MagneChef, a direct-to-consumer brand leveraging proprietary IP for innovative kitchen products. The Company is also committed to social responsibility through the Earth Science Foundation, a non-profit dedicated to assisting patients with prescription costs.
Except for historical information, the matters discussed herein may be considered “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.
Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,” “intend,” “belief,” “plan,” “estimate,” “target,” “predict,” “likely,” “seek,” “project,” “model,” “ongoing,” “will,” “should,” “forecast,” “outlook” or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company's actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company's products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.
Earth Science Tech, Inc. and Subsidiaries Consolidated Balance Sheets (Unaudited)
As of December 31, 2025
As of March 31, 2025
ASSETS
Current Assets:
Cash and cash equivalents
$
415,699
$
1,473,228
Accounts Receivable
306,118
129,064
Equity Investments at fair value
1,126,307
645,438
Inventory
1,088,019
503,938
Deposits
57,631
338,108
Prepaid
39,159
20,730
Total current assets
3,032,933
3,110,505
Non-Current Assets:
Property and Equipment, net
1,890,801
1,384,110
Right of use asset, net
139,231
172,429
Goodwill
2,648,788
2,302,792
Intangible Assets, net
377,684
96,885
Total Assets
$
8,089,437
$
7,066,721
LIABILITIES AND EQUITY
Accounts payable
$
1,088,521
$
492,352
Accrued expenses and other payable
1,019,036
2,322,022
Current portion of operating lease obligations
121,851
121,851
Current portion of equipment loan
30,592
30,592
Short-term business loan
–
179,488
Total Current Liabilities
2,260,000
3,146,305
Long-Term Liabilities:
Lease liability less current maturities
18,177
37,878
Equipment loan, non-current
8,254
31,427
Total Liabilities
2,286,431
3,215,610
Commitment and Contingencies (Note 11)
Stockholders' Equity:
Preferred stock, par value $0.001 per share, 1,000,000 shares authorized; 1,000,000 and 0 shares issued and outstanding as of December 31, 2025, and March 31, 2025, respectively
1,000
1,000
Common stock, par value $0.001 per share, 300,000,000 shares authorized; 291,644,607 issued and 291,609,607 outstanding, and 295,347,903 issue and 294,302,607 outstanding as of December 31, 2025, and March 31, 2025, respectively
291,644
295,348
Additional paid-in capital
30,836,759
31,480,143
Accumulated deficit
(25,396,738
)
(27,738,975
)
Treasury Stock, at cost 35,000 and 1,045,296 shares as of December 31, 2025, and March 31, 2025, respectively
(5,525
)
(186,404
)
Non-Controlling Interest
75,866
–
Total stockholders' Equity
5,803,006
3,851,111
Total Liabilities and Equity
$
8,089,437
$
7,066,721
Earth Science Tech, Inc. and Subsidiaries Consolidated Statements of Operations For Three and Nine months ended December 31, 2025, and 2024 (Unaudited)
For the Three Months Ended December 31,
For the Nine Months Ended December 31,
2025
2024
2025
2024
Revenue
$
8,386,779
7,352,635
$
26,197,596
$
24,440,600
Cost of Goods Sold
1,987,769
2,265,762
6,983,827
6,676,612
Gross Profit
6,399,010
5,086,873
19,213,769
17,763,988
Expenses
Salaries Expense
2,931,244
3,297,826
10,787,357
10,372,308
Office/Selling, General and Administrative Expenses
914,029
809,850
2,741,912
3,455,474
Advertising & marketing
708,511
346,109
2,082,463
511,455
Bank charges
250,332
210,549
725,340
770,849
Legal & Professional Fees
56,022
61,540
138,141
243,245
Insurance
40,318
79,569
126,863
160,395
Depreciation and Amortization
121,790
44,778
342,751
108,201
Utilities
34,743
10,426
102,769
21,257
Total Expenses
5,056,988
4,860,647
17,047,597
15,643,184
Other Income/Expenses
Dividend Income
4,537
9,123
13,944
9,123
Interest earned
457
16
2,259
13,216
Net realized gain on sale of investments
309,807
174,613
536,951
174,613
Unrealized Gain/Loss of fair value changes of investments
(613,741
)
(197,277
)
(262,067
)
(197,277
)
Interest Expenses
(4,769
)
(6,290
)
(16,335
)
(11,097
)
Net Income before taxes
1,038,314
206,411
2,440,925
2,109,382
Income Tax
127,946
–
127,946
28,349
Net Income
910,367
206,411
2,312,978
2081,033
Net Income/(Loss) attributed to non-controlling interest
(9
)
–
(29,250
)
–
Net Income attributed to shareholders
910,376
206,411
2,342,237
2,081,382
Net Income per common share-Basic and Diluted
0.003
0.001
0.008
0.007
Weighted average number of common shares outstanding basic and diluted
